Vascular Inflammation: A Novel Access Route for Nanomedicine
References
- Falk E. Pathogenesis of atherosclerosis. J Am Coll Cardiol. 2006 Apr; 47( 8s1): C7– C12.
- Mozaffarian D , Benjamin EJ , Go AS , Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association. Circulation. 2016 Jan 26; 133( 4): e38– e360.
- Cooke JP. Flow, NO, and atherogenesis. Proc Natl Acad Sci U S A. 2003 Feb 4; 100( 3): 768– 70.
- Strong JP , Malcom GT , McMahan CA , Prevalence and extent of atherosclerosis in adolescents and young adults: implications for prevention from the Pathobiological Determinants of Atherosclerosis in Youth Study. JAMA. 1999 Feb 24; 281( 8): 727– 35.
- Cartier A , Lemieux I , Alméras N , Tremblay A , Bergeron J , Després JP. Visceral obesity and plasma glucose-insulin homeostasis: contributions of interleukin-6 and tumor necrosis factor-alpha in men. J Clin Endocrinol Metab. 2008 May; 93( 5): 1931– 8.
- Abeywardena MY , Leifert WR , Warnes KE , Varghese JN , Head RJ. Cardiovascular biology of interleukin-6. Curr Pharm Des. 2009; 15( 15): 1809– 21.
- Ridker PM. High-sensitivity C-reactive protein and cardiovascular risk: rationale for screening and primary prevention. Am J Cardiol. 2003 Aug 21; 92( 4B): 17K– 22K.
- Goldberg RB. Cytokine and cytokine-like inflammation markers, endothelial dysfunction, and imbalanced coagulation in development of diabetes and its complications. J Clin Endocrinol Metab. 2009 Sep; 94( 9): 3171– 82.
- Libby P. Inflammation in atherosclerosis. Nature. 2002 Dec 19–26; 420( 6917): 868– 74.
- Roman MJ , Shanker BA , Davis A , Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. N Engl J Med. 2003 Dec 18; 349( 25): 2399– 406.
- Anker SD von Haehling S. Inflammatory mediators in chronic heart failure: an overview. Heart. 2004 Apr; 90( 4): 464– 70.
- Vallance P , Collier J , Bhagat K. Infection, inflammation, and infarction: does acute endothelial dysfunction provide a link? Lancet. 1997 May 10; 349( 9062): 1391– 2.
- Levi M , van der Poll T , Büller HR. Bidirectional relation between inflammation and coagulation. Circulation. 2004 Jun 8; 109( 22): 2698– 704.
- Wagner DD Burger PC. Platelets in inflammation and thrombosis. Arterioscler Thromb Vasc Biol. 2003 Dec; 23( 12): 2131– 7.
- Skålén K , Gustafsson M , Rydberg EK , Subendothelial retention of atherogenic lipoproteins in early atherosclerosis. Nature. 2002 Jun 13; 417( 6890): 750– 4.
- Kones R Rumana U. Current treatment of dyslipidemia: evolving roles of non-statin and newer drugs. Drugs. 2015 Jul; 75( 11): 1201– 28.
- Ansell BJ , Watson KE , Fogelman AM , Navab M , Fonarow GC. High-density lipoprotein function recent advances. J Am Coll Cardiol. 2005 Nov 15; 46( 10): 1792– 8.
- Esdaile JM , Abrahamowicz M , Grodzicky T , Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus. Arthritis Rheum. 2001 Oct; 44( 10): 2331– 7.
- Krauss RM , Winston M , Fletcher BJ , Grundy SM. Obesity: impact on cardiovascular disease. Circulation. 1998 Oct 6; 98( 14): 1472– 76.
- Goldstein JL , Ho YK , Basu SK , Brown MS. Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. Proc Natl Acad Sci U S A. 1979 Jan; 76( 1): 333– 7.
- Libby P , Ridker PM , Hansson GK. Progress and challenges in translating the biology of atherosclerosis. Nature. 2011 May 19; 473( 7347): 317– 25.
- Jun M , Foote C , Lv J , Effects of fibrates on cardiovascular outcomes: a systematic review and meta-analysis. Lancet. 2010 May 29; 375( 9729): 1875– 84.
- Li S , Gokden N , Okusa MD , Bhatt R , Portilla D. Anti-inflammatory effect of fibrate protects from cisplatin-induced ARF. Am J Physiol Renal Physiol. 2005 Aug; 289( 2): F469– 80.
- Husain S , Andrews NP , Mulcahy D , Panza JA , Quyyumi AA. Aspirin improves endothelial dysfunction in atherosclerosis. Circulation. 1998 Mar 3; 97( 8): 716– 20.
- Münzel T Keaney JF. Are ACE inhibitors a “magic bullet” against oxidative stress? Circulation. 2001 Sep 25; 104( 13): 1571– 4.
- Molinaro R , Wolfram J , Federico C , Polyethylenimine and chitosan carriers for the delivery of RNA interference effectors. Expert Opin Drug Deliv. 2013 Dec; 10( 12): 1653– 68.
- Chacko AM , Hood ED , Zern BJ , Muzykantov VR. Targeted nano-carriers for imaging and therapy of vascular inflammation. Curr Opin Colloid Interface Sci. 2011 Jun; 16( 3): 215– 27.
- Muzykantov VR. Targeted therapeutics and nanodevices for vascular drug delivery: quo vadis? IUBMB Life. 2011 Aug; 63( 8): 583– 5.
- Howard M , Zern BJ , Anselmo AC , Shuvaev VV , Mitragotri S , Muzykantov V. Vascular Targeting of Nanocarriers: Perplexing Aspects of the Seemingly Straightforward Paradigm. ACS Nano. 2014 May 27; 8( 5): 4100– 32.
- Wagner DD Frenette PS. The vessel wall and its interactions. Blood. 2008 Jun 1; 111( 11): 5271– 81.
- Ruiz-Esparza GU , Segura-Ibarra V , Cordero-Reyes AM , A specifically designed nanoconstruct associates, internalizes, traffics in cardiovascular cells, and accumulates in failing myocardium: a new strategy for heart failure diagnostics and therapeutics. Eur J Heart Fail. 2016 Feb; 18( 2): 169– 78.
- Yang H , Zhao F , Li Y , VCAM-1-targeted core/shell nanoparticles for selective adhesion and delivery to endothelial cells with lipopolysaccharide-induced inflammation under shear flow and cellular magnetic resonance imaging in vitro. Int J Nanomedicine. 2013; 8: 1897– 906.
- Robbins GP , Saunders RL , Haun JB , Rawson J , Therien MJ , Hammer DA. Tunable leuko-polymersomes that adhere specifically to inflammatory markers. Langmuir. 2010 Sep 7; 26( 17): 14089– 96.
- Li D , Patel AR , Klibanov AL , Molecular imaging of athero-sclerotic plaques targeted to oxidized LDL receptor LOX-1 by SPECT/CT and magnetic resonance. Circ Cardiovasc Imaging. 2010 Jul; 3( 4): 464– 72.
-
Homem de Bittencourt
PI
Jr , Lagranha DJ , Maslinkiewicz A , LipoCardium: endothelium-directed cyclopentenone prostaglan-din-based liposome formulation that completely reverses atherosclerotic lesions. Atherosclerosis. 2007 Aug; 193( 2): 245– 58. - Cyrus T , Zhang H , Allen JS , Intramural delivery of rapamycin with alphavbeta3-targeted paramagnetic nanoparticles inhibits stenosis after balloon injury. Arterioscler Thromb Vasc Biol. 2008 May; 28( 5): 820– 6.
- Chorny M , Fishbein I , Yellen BB , Targeting stents with local delivery of paclitaxel-loaded magnetic nanoparticles using uniform fields. Proc Natl Acad Sci U S A. 2010 May 4; 107( 18): 8346– 51.
- Myerson J , He L , Lanza G , Tollefsen D , Wickline S. Thrombin-inhibiting perfluorocarbon nanoparticles provide a novel strategy for the treatment and magnetic resonance imaging of acute thrombosis. J Thromb Haemost. 2011 Jul; 9( 7): 1292– 300.
- Yoo JW , Irvine DJ , Discher DE , Mitragotri S. Bio-inspired, bio-engineered and biomimetic drug delivery carriers. Nat Rev Drug Discov. 2011 Jul 1; 10( 7): 521– 35.
- Hu CM , Fang RH , Wang KC , Nanoparticle biointerfacing by platelet membrane cloaking. Nature. 2015 Oct 1; 526( 7571): 118– 21.
- Parodi A , Quattrocchi N , van de Ven AL , Synthetic nanoparticles functionalized with biomimetic leukocyte membranes possess cell-like functions. Nat Nanotechnol. 2013 Jan; 8( 1): 61– 8.
- McMahon KM , Mutharasan RK , Tripathy S , Biomimetic high density lipoprotein nanoparticles for nucleic acid delivery. Nano Lett. 2011 Mar 9; 11( 3): 1208– 14.
- Allijn IE , Leong W , Tang J , Gold nanocrystal labeling allows low-density lipoprotein imaging from the subcellular to macroscopic level. ACS Nano. 2013 Nov 26; 7( 11): 9761– 70.
- Zhang W , He H , Liu J , Pharmacokinetics and atherosclerotic lesions targeting effects of tanshinone IIA discoidal and spherical biomimetic high density lipoproteins. Biomaterials. 2013 Jan; 34( 1): 306– 19.
- Molinaro R , Corbo C , Martinez JO , Biomimetic proteolipid vesicles for targeting inflamed tissues. Nat Mater. 2016; doi: 10.1038/NMAT4644. In Press.
- Jain MK Ridker PM. Anti-inflammatory effects of statins: clinical evidence and basic mechanisms. Nat Rev Drug Discov. 2005 Dec; 4( 12): 977– 87.
DOI: https://doi.org/10.14797/mdcj-12-3-169 | Journal eISSN: 1947-6108
Language: English
Page range: 169 - 174
Published on: Jul 1, 2016
Published by: Houston Methodist DeBakey Heart & Vascular Center
In partnership with: Paradigm Publishing Services
Keywords:
© 2016 Roberto Molinaro, Christian Boada, Guillermo Medrano del Rosal, Kelly A. Hartman, Claudia Corbo, Elizabeth D. Andrews, Naama E. Toledano-Furman, John P. Cooke, Ennio Tasciotti, published by Houston Methodist DeBakey Heart & Vascular Center
This work is licensed under the Creative Commons Attribution-NonCommercial 4.0 License.